<DOC>
	<DOCNO>NCT01792583</DOCNO>
	<brief_summary>The primary objective Nuvigil/Provigil Pregnancy Registry characterize pregnancy fetal outcomes associate Nuvigil Provigil exposure pregnancy .</brief_summary>
	<brief_title>The Nuvigil Provigil Pregnancy Registry</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Reported exposure Nuvigil ( armodafinil ) and/or brand generic formulation Provigil ( modafinil ) within 6 week become pregnant , pregnancy Able willing provide inform consent Able willing provide healthcare professional secondary contact information , patient contact periodically Registry staff Patients refuse provide oral write informed consent Patients expose armodafinil brand generic formulation modafinil Pregnancy outside United States</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pregnancy</keyword>
</DOC>